Literature DB >> 33854268

New frontiers in endovascular therapies for locally advanced hepatocellular carcinoma.

Riccardo Inchingolo1,2, Stavros Spiliopoulos3, Alessandro Posa4, Tiago Kojun Tibana5, Thiago Franchi Nunes5, Riccardo Memeo6.   

Abstract

Hepatocellular carcinoma is the most common primary malignant liver tumour and is a leading cause of death worldwide. Despite the advent of screening programmes, most cases of hepatocellular carcinoma are diagnosed late (in an advanced stage) which precludes curative treatments such as surgery and ablation. Therefore, intra-arterial locoregional treatments now play a central role in the management of advanced hepatocellular carcinoma, such treatments ranging from trans-arterial chemo-embolisation to the more recently developed trans-arterial radio-embolisation technique. In this essay, we discuss the state of the art of intra-arterial treatment for locally advanced hepatocellular carcinoma and the future directions for such treatment.

Entities:  

Keywords:  Carcinoma, hepatocellular/therapy; Chemoembolization, therapeutic; Fibrosis; Liver neoplasms/radiotherapy; Liver/pathology; Medical oncology/methods

Year:  2021        PMID: 33854268      PMCID: PMC8029933          DOI: 10.1590/0100-3984.2020.0027

Source DB:  PubMed          Journal:  Radiol Bras        ISSN: 0100-3984


  10 in total

Review 1.  Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art.

Authors:  Roberto Iezzi; Maurizio Pompili; Alessandro Posa; Giuseppe Coppola; Antonio Gasbarrini; Lorenzo Bonomo
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

2.  Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials.

Authors:  J Bruix; A Castells; X Montanyà; X Calvet; C Brú; C Ayuso; L Jover; L García; R Vilana; L Boix
Journal:  Hepatology       Date:  1994-09       Impact factor: 17.425

3.  Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.

Authors:  Michael Ginsburg; Sean P Zivin; Kristen Wroblewski; Taral Doshi; Raj J Vasnani; Thuong G Van Ha
Journal:  J Vasc Interv Radiol       Date:  2014-12-18       Impact factor: 3.464

4.  Single-Agent versus Combination Doxorubicin-Based Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Single-Blind, Randomized, Phase II Trial.

Authors:  Bing Liu; Jian-wen Huang; Yong Li; Bao-shan Hu; Xu He; Wei Zhao; You-bing Zheng; Li-gong Lu
Journal:  Oncology       Date:  2015-01-21       Impact factor: 2.935

5.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

6.  Comparison of single-session transarterial chemoembolization combined with microwave ablation or radiofrequency ablation in the treatment of hepatocellular carcinoma: a randomized-controlled study.

Authors:  Elshazly Sheta; Ferial El-Kalla; Mohamed El-Gharib; Abdelrahman Kobtan; Mohammed Elhendawy; Sherief Abd-Elsalam; Loai Mansour; Ibrahim Amer
Journal:  Eur J Gastroenterol Hepatol       Date:  2016-10       Impact factor: 2.566

Review 7.  Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.

Authors:  Luigi Bolondi; Andrew Burroughs; Jean-François Dufour; Peter R Galle; Vincenzo Mazzaferro; Fabio Piscaglia; Jean Luc Raoul; Bruno Sangro
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

8.  International incidence and mortality trends of liver cancer: a global profile.

Authors:  Martin C S Wong; Johnny Y Jiang; William B Goggins; Miaoyin Liang; Yuan Fang; Franklin D H Fung; Colette Leung; Harry H X Wang; Grace L H Wong; Vincent W S Wong; Henry L Y Chan
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

Review 9.  Update on Transarterial Chemoembolization with Drug-Eluting Microspheres for Hepatocellular Carcinoma.

Authors:  Yasir M Nouri; Jin Hyoung Kim; Hyun-Ki Yoon; Heung-Kyu Ko; Ji Hoon Shin; Dong Il Gwon
Journal:  Korean J Radiol       Date:  2018-12-27       Impact factor: 3.500

10.  Polyethylene glycol microspheres loaded with irinotecan for arterially directed embolic therapy of metastatic liver cancer.

Authors:  Giammaria Fiorentini; Riccardo Carandina; Donatella Sarti; Michele Nardella; Odysseas Zoras; Stefano Guadagni; Riccardo Inchingolo; Massimiliano Nestola; Alessandro Felicioli; Daniel Barnes Navarro; Fernando Munoz Gomez; Camillo Aliberti
Journal:  World J Gastrointest Oncol       Date:  2017-09-15
  10 in total
  2 in total

1.  Locoregional therapies for the treatment of locally advanced hepatocellular carcinoma.

Authors:  Joaquim Maurício da Motta-Leal-Filho
Journal:  Radiol Bras       Date:  2021 May-Jun

2.  Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report.

Authors:  Ming-Hui Sun; Wei-Dong Yi; Ling Shen; Lu Zhou; Jian-Xun Lu
Journal:  World J Clin Cases       Date:  2022-07-26       Impact factor: 1.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.